Rubella Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella
Conditions:   Rubella;   Measles Interventions:   Biological: Measles and Rubella vaccine;   Biological: Measles, Mumps and Rubella vaccine Sponsors:   The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz);   Oswaldo Cruz Institute Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2017 Category: Research Source Type: clinical trials

Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age
Conditions:   Measles;   Rubella;   Rubella Syndrome, Congenital Interventions:   Biological: Measles-rubella (MR) vaccine at 6 and 9 months;   Biological: Measles-rubella (MR) vaccine at 9 months Sponsors:   Centers for Disease Control and Prevention;   The International Centre for Diarrhoeal Disease Research, Bangladesh;   Ministry of Health and Family Welfare, Bangladesh Not yet recruiting - verified March 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2017 Category: Research Source Type: clinical trials